| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 07/05/2024 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Participate at Upcoming Investor Conferences | NASDAQ:CDMO | Avid Bioservices Inc |
| 24/04/2024 | 23:25 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 | NASDAQ:CDMO | Avid Bioservices Inc |
| 20/03/2024 | 12:00 | GlobeNewswire Inc. | Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q | NASDAQ:CDMO | Avid Bioservices Inc |
| 07/03/2024 | 12:30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CDMO | Avid Bioservices Inc |
| 07/03/2024 | 05:58 | GlobeNewswire Inc. | Avid Bioservices Announces Pricing of Private Placement of Convertible Notes | NASDAQ:CDMO | Avid Bioservices Inc |
| 06/03/2024 | 22:32 | GlobeNewswire Inc. | Avid Bioservices Announces Proposed Private Placement of Convertible Notes | NASDAQ:CDMO | Avid Bioservices Inc |
| 06/03/2024 | 22:31 | GlobeNewswire Inc. | Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 | NASDAQ:CDMO | Avid Bioservices Inc |
| 26/01/2024 | 22:57 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:CDMO | Avid Bioservices Inc |
| 13/01/2024 | 01:34 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CDMO | Avid Bioservices Inc |
| 19/12/2023 | 22:05 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:CDMO | Avid Bioservices Inc |
| 07/12/2023 | 22:48 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:CDMO | Avid Bioservices Inc |
| 07/12/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023 | NASDAQ:CDMO | Avid Bioservices Inc |
| 02/12/2023 | 00:16 | PR Newswire (US) | Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 | NASDAQ:CDMO | Avid Bioservices Inc |
| 30/11/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023 | NASDAQ:CDMO | Avid Bioservices Inc |
| 17/11/2023 | 22:35 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:CDMO | Avid Bioservices Inc |
| 08/11/2023 | 14:05 | GlobeNewswire Inc. | Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs | NASDAQ:CDMO | Avid Bioservices Inc |
| 17/10/2023 | 14:05 | GlobeNewswire Inc. | Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility | NASDAQ:CDMO | Avid Bioservices Inc |
| 11/10/2023 | 03:19 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:CDMO | Avid Bioservices Inc |
| 26/09/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference | NASDAQ:CDMO | Avid Bioservices Inc |
| 07/09/2023 | 23:00 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:CDMO | Avid Bioservices Inc |
| 07/09/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023 | NASDAQ:CDMO | Avid Bioservices Inc |
| 31/08/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023 | NASDAQ:CDMO | Avid Bioservices Inc |
| 28/08/2023 | 22:59 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:CDMO | Avid Bioservices Inc |
| 28/08/2023 | 22:58 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:CDMO | Avid Bioservices Inc |
| 21/06/2023 | 23:01 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CDMO | Avid Bioservices Inc |
| 21/06/2023 | 22:47 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CDMO | Avid Bioservices Inc |
| 21/06/2023 | 22:07 | GlobeNewswire Inc. | Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023 | NASDAQ:CDMO | Avid Bioservices Inc |
| 14/06/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023 | NASDAQ:CDMO | Avid Bioservices Inc |
| 09/06/2023 | 01:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CDMO | Avid Bioservices Inc |
| 10/05/2023 | 22:05 | GlobeNewswire Inc. | Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference | NASDAQ:CDMO | Avid Bioservices Inc |